PharMEDium Buffered Lidocaine Syringe Label Mixup Recall
PharMEDium recalls 1% Lidocaine syringes with incorrect labeling as 1% instead of 0.9%. This mix-up could lead to improper dosing if used without checking the label.
Lower-risk recall
Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%
Contact the company
What happened, in plain English
PharMEDium is recalling syringes labeled incorrectly as 1% Lidocaine when they should be 0.9%. This mix-up could cause incorrect dosing if used without verifying the label. Read more at govinfonow.com/recall/42066-pharmedium-buffered-lidocaine-syringe-label-mixup-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/42066-pharmedium-buffered-lidocaine-syringe-label-mixup-recall · Updated October 8, 2026 · FDA enforcement record: FDA #D-0603-2017
Cite this page
“PharMEDium Buffered Lidocaine Syringe Label Mixup Recall.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42066-pharmedium-buffered-lidocaine-syringe-label-mixup-recall. Based on FDA recall #D-0603-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0603-2017%22&limit=1).
Why it’s dangerous
The syringe is incorrectly labeled as 1% Lidocaine instead of the correct 0.9%. This mix-up could lead to improper dosing if the user assumes it's the higher concentration without checking the label.
Who’s affected
People who received the specific lot numbers of the syringe labeled as 1% Lidocaine (not 0.9%) may be affected. Healthcare providers using these syringes for local anesthesia are most at risk.
How to tell if you have this one
Check for the product code 2K2466 on the syringe. Look for lot numbers 170110030M, 170110029M, or 170070058M. The syringe is labeled as 'Buffered Lidocaine 1%' instead of 'Buffered Lidocaine 0.9%'.
- Brand
PharMEDium- Category
Drug
What to do — step by step
Check Label Carefully
Verify the label states 'Buffered Lidocaine 0.9%' instead of '1%' before use.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 48 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- FDA terminated the recall
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product dangerous if used correctly?
No, the product is safe if the label is checked correctly. The recall is due to labeling error, not safety risk.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0603-2017 (January 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0603-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.